facebook twitter linkedin

This material was prepared by a third party towards Selvita S.A. with its registered office in Kraków (hereunder: “Selvita”). Within the scope which was not authorized by Selvita’s management board, the description of factual circumstances regarding the activities of Selvita, embodied in this material presents merely opinion of the third party, in particular with respect to presented opinions, predictions, appraisals and forecasts of the financial data and future activity of Selvita and its results.

Therefore, Selvita does not warrant consistency of this material with the actual and legal situation. Neither Selvita, members of its corporate bodies, employees nor its consultants shall bear any liability for validity of opinions, predictions, appraisals, forecasts and any other date embodied in this material as well as for consequences of actions of any reader made on a basis of this material, in particular for the investment decisions or any losses resulting from use of this material.

Readers of this material shall make its own assessment, whether opinions or forecasts embodied therein are credible and adequate, in particular taking into account their investment strategy and actual and legal situation. In particular they should consult it with their independent financial and investment advisors. None of the information presented in this material shall constitute investment, legal, accounting or tax advice or a statement that any investment strategy is accurate or adequate, considering the circumstances of the reader.

Furthermore date presented in this material shall not constitute an offer to sell or purchase any financial instruments nor an invite the make such offer. It shall not be also not deemed as a recommendation for investment in any financial instrument nor an advertisement of such instruments.



DISAGREE AGREE

  •   October 24, 2011, Krakow, Poland - Selvita, Polish biotechnology company engaged in the discovery and development of breakthrough medicines to treat CNS and oncology disorders, as well as provision of non-clinical research services,presented data from two of its oncology programs at the 2011 AACR-EORTC-NCI Molecular Targets and Cancer...
  •   18th October 2011 - Selvita S.A. has been ranked as the no. 1 Rising Star within this year's contest of Deloitte Technology Fast 50 in Central Europe.The Central Europe Technology Fast 50 program, is part of a global effort by Deloitte to identify the fastest growing technology companies all over the world, which became a recognized...
  • Location: 31st October - 2nd November 2011, Duesseldorf, Germany   BIO-Europe is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is...
  •   Kraków, 26th September 2011 -  Selvita S.A., Poland based integrated drug discovery services provider, announced today signature of an agreement with Evestra GmbH (Germany), a subsidiary of Evestra Inc (USA), for the delivery of a series of drug metabolism, pharmacokinetic (DMPK) and physicochemical studies.   The contracted...
  • Place: 11th-13th October 2011, Hannover Exhibition Grounds, Germany   Bio-IT World Europe 2011 will bring together, for the third time, life sciences, pharmaceutical, informatics and IT professionals from all over Europe and the rest of the world to one unique location. This event provides the perfect venue to share information and discuss...
  • Place: 25th - 27th October 2011, Messe Frankfurt, Germany Selvita will participate in one of the greatest pharmaceutical events this year. ICSE | BioPh and InnoPack 2011, along with co-located events CPhI Worldwide for Pharmaceutical Ingredients and P-MEC Europe for Pharmaceutical Machinery, Equipment and Technology, are an unrivalled networking...
  • Place: 7th - 9th September 2011, Boston, MA, USA   Selvita participates in the 4th Annual International Partnering Conference - BioPharm America 2011. BioPharm America is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter...
  • Most recent - Q3 2011 - Selvita newsletter available to download.
  • Place: London, 17 June 2011, London Stock Exchange, London, UK   The 2011 BIA BioFinance and BioInnovate Europe conference is focused on life sciences as an enabling technology, bringing benefits to patients, economies and investors. With a range of top-level speakers from global pharma and bioscience companies of all sizes,...
  • Place: 27-30th June 2011, Washington, DC, USAThe BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.During the 2011 edition of BIO,...
  • Place: 25-29th June 2011, Palais des Congres, Paris, France   The World Congress on Inflammation is a biennal congress organized by the International Association of Inflammation Societies, which is a non-profit making organization which aims to promote international co-operation among inflammation scientists as well as...
  • On 19 May 2011, BioCentrum, part of the Selvita Group, received a certificate of compliance with the principles of Good Laboratory Practice (GLP). The certificate was awarded after a successfully completed verification by the Bureau for Chemical Substances (institution of governmental administration granting GLP certificates) .   GLP...
  •     Kraków, 13 May 2011  -  On 12 May 2011, during this year’s edition of the “Masters of Innovation” competition, organized along with the Central European Forum of Biotechnology and Innovative BioEconomy – BioForum 2011, Selvita was voted the most innovative biotechnology company in the region. The...
  •   Place: 15th-16th June 2011, Hall 1 Palexpo, Geneva, Switzerland   Chemspec Europe returns to the PALEXPO in Geneva, Switzerland in 2011.  Geneva will host the 26th Chemspec Europe which will see over 400 exhibiting companies from around the globe and in excess of 5,000 attendees. Some of the world’s largest suppliers of...
  • Place: 16th June 2011, Søhuset Conference Center, Hørsholm, Denmark    Biotech Outsourcing Strategies cmc2011 (BOScmc), is one of the leading outsourcing focused partnering events for chemistry, manufacturing and controls (CMC) professionals. The event will also be featuring two lecture tracks for small molecule and...
  • Place: 6th - 8th June 2011, Royal Sonesta Hotel, Boston, USA   Cambridge Healthtech Institute’s 11th Annual Structure-Based Drug Design conference brings to focus the latest development in computational technology for drug discovery, and puts structure-based molecular approaches into the perspective of targeted...
  • Place: 3rd-7th June 2011, McCormick Place, Chicago, IL, USA   Selvita participates in the 2011 edition of ASCO Annual Meeting. The 2011 Annual Meeting will center on a theme of "Patients, Pathways, Progress." The event will be filled with cutting-edge scientific presentations and comprehensive educational content, as well as it will...
  •   Kraków, 5th May 2011 - The largest Polish drug discovery company Selvita announced today it has entered into definitive agreements with investors in Poland to sell in a private placement 2,7 million shares of its stock at a price of PLN 5.5 per share, resulting in gross proceeds to the company of PLN 14,85 million ($ 5.5...
  • New issue of Selvita Newsletter available to download now!
  • The newest issue of Selvita's Newsletter is available now!
  • Kraków 4 April 2011 - Selvita signs a computational chemistry services agreement with The Institutes for Pharmaceutical Discovery, USA .   Selvita, Poland based integrated discovery partner for the pharmaceutical and biotechnology industry, announced today an agreement with the Institutes for Pharmaceutical Discovery (IPD) in Branford, CT,...
  • BioCentrum (Selvita Group) and the Institute of Biotechnology and Antibiotics announced commencement of cooperation concerning conduction of crystallography studies as an element of preparation of the registration dossier for a medicinal product.    Institute of Biotechnology and Antibiotics as a coordinator of the consortium of...
  • Selvita Group and Polfa Warszawa announce commencement of a collaboration concerning the analytical work necessary to prepare the registration dossier for a medicinal product.    The scope of the project, commissioned to Selvita Group, includes development, validation and transfer of analytical methods for characterizing substances...
  • Place: Paris, 23rd-24th May, 2011, Paris Marriott Rive Gauche, Paris, France   Selvita will present during the upcoming BioEquity Europe conference in Paris. BioEquity Europe has become a magnet for financial and pharmaceutical company dealmakers, and is the premier venue for biopharma companies looking to attract capital and expand...
  •   The 1st issue of quarterly Selvita newsletter is available now !    Download Selvita newsletter for 1Q2011
  • Place: 28th February - 1st March 2011, Hotel Cascais Miragem, Cascais, Portugal   euroPLX Meetings are the place for pharma deals, attended by industry executives in charge of business development, commercial operations, marketing, and brokers or consultants with clear mandates. euroPLX delivers an average of more than 23...
  • Place: Munich, 28th-29th March 2011, Holiday Inn, Munich, Germany.   Selvita will participate in the 3rd Annual Pharma Outsourcing Congress, which this year will take place in Munich, Germany. Congress is focused on outsourcing of Drug Discovery activities and clinical trials. The agenda for this years event includes following...
  • Place: London, 19th-20th January 2011, Radisson Blu Portman Hotel   With businesses under more pressure to innovate than ever before, regardless of the cost-cutting climate, now is the time to find ways to  enhance the product pipeline and drive new drugs to market and emerge from the economic crisis with the competitive...
  • Place: Zurich, January 25th-26th, 2011, Radisson Blu Hotel (Zurich Airport)   Building on the success of the 2010 event, the 4th Annual European Life Science CEO Forum for Partnering and Investing is an exclusive and highly transactional forum for investing and partnering in the Biotech and Pharma industry. Attended by 300...